``We have a lot of evidence that this is likely to be, if not the final cause, at least a major part of the disease process,'' said New Zealand biochemist Garth Cooper.
The research ``opens the door to the scientific study of the disease at a level that wasn't possible before and
Cooper, who has been working with scientists at Oxford University, described the hormone research this week at the 13th International Diabetes Federation Congress in Sydney, Australia.
Scientists already knew of another pancreatic hormone that blocks insulin, but it is not found in abnormal levels in diabetics, said Pi-Sunyer, director of the endocrinology, diabetes and nutrition division at St. Luke's-Roosevelt Hospital Center in New York.
